alt-801
Showing 1 - 10 of 10
Type 2 Diabetes Trial (ALT-801, Placebo)
Active, not recruiting
- Type 2 Diabetes
- ALT-801
- Placebo
-
Fort Myers, Florida
- +6 more
Oct 11, 2022
Non-Alcoholic Fatty Liver Disease Trial in United States (ALT-801, Placebo)
Active, not recruiting
- Non-Alcoholic Fatty Liver Disease
- ALT-801
- Placebo
-
Montclair, California
- +12 more
Oct 11, 2022
NASH - Nonalcoholic Steatohepatitis Trial in Herston (ALT-801, Placebo)
Completed
- NASH - Nonalcoholic Steatohepatitis
- ALT-801
- Placebo
-
Herston, Queensland, AustraliaNucleus Networks
Nov 8, 2021
NASH - Nonalcoholic Steatohepatitis Trial in Herston, Adelaide (ALT-801, Metformin, Atorvastatin)
Recruiting
- NASH - Nonalcoholic Steatohepatitis
- ALT-801
- +5 more
-
Herston, Queensland, Australia
- +1 more
Nov 8, 2021
Non-Alcoholic Fatty Liver Disease Trial in United States (ALT-801, Placebo)
Active, not recruiting
- Non-Alcoholic Fatty Liver Disease
- ALT-801
- Placebo
-
Scottsdale, Arizona
- +14 more
Jun 30, 2022
Obesity/Overweight Trial in Los Angeles, Indianapolis (ALT-801, Placebo)
Active, not recruiting
- Obesity/Overweight
- ALT-801
- Placebo
-
Birmingham, Alabama
- +30 more
Sep 7, 2022
Non-muscle Invasive Bladder Cancer Trial in United States (ALT-801, Gemcitabine)
Unknown status
- Non-muscle Invasive Bladder Cancer
- ALT-801
- Gemcitabine
-
Birmingham, Alabama
- +4 more
Jan 23, 2017
Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer Trial in United States (Cisplatin, Gemcitabine, ALT-801)
Unknown status
- Transitional Cell Carcinoma of Bladder
- +3 more
- Cisplatin
- +2 more
-
Tucson, Arizona
- +15 more
Apr 11, 2016